Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
256.14
-0.48 (-0.19%)
At close: Aug 7, 2025, 4:00 PM
256.03
-0.11 (-0.04%)
After-hours: Aug 7, 2025, 7:58 PM EDT
Accolade Stock Forecast
Stock Price Forecast
The 20 analysts that cover Accolade stock have a consensus rating of "Hold" and an average price target of $277.05, which forecasts a 8.16% increase in the stock price over the next year. The lowest target is $250 and the highest is $326.
Price Target: $277.05 (+8.16%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Accolade stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 5 | 5 | 6 | 5 | 5 | 5 |
Hold | 17 | 17 | 15 | 15 | 15 | 15 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 23 | 23 | 22 | 21 | 21 | 21 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Hold Maintains $268 → $275 | Hold | Maintains | $268 → $275 | +7.36% | Jul 31, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $290 → $277 | Hold | Maintains | $290 → $277 | +8.14% | Jul 31, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $288 → $272 | Hold | Maintains | $288 → $272 | +6.19% | Jul 31, 2025 |
Baird | Baird | Hold Maintains $300 → $297 | Hold | Maintains | $300 → $297 | +15.95% | Jul 25, 2025 |
Truist Securities | Truist Securities | Hold Maintains $280 → $260 | Hold | Maintains | $280 → $260 | +1.51% | Jul 16, 2025 |
Financial Forecast
Revenue This Year
128.01B
from 117.76B
Increased by 8.70%
Revenue Next Year
131.72B
from 128.01B
Increased by 2.90%
EPS This Year
16.53
from 9.98
Increased by 65.61%
EPS Next Year
14.23
from 16.53
Decreased by -13.91%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 134.4B | 143.9B | 156.2B | ||
Avg | 128.0B | 131.7B | 141.9B | ||
Low | 122.4B | 118.6B | 123.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 14.2% | 12.4% | 18.6% | ||
Avg | 8.7% | 2.9% | 7.7% | ||
Low | 3.9% | -7.4% | -6.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 17.83 | 19.30 | 28.73 | ||
Avg | 16.53 | 14.23 | 21.89 | ||
Low | 15.93 | 8.82 | 18.08 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 78.6% | 16.8% | 101.9% | ||
Avg | 65.6% | -13.9% | 53.8% | ||
Low | 59.6% | -46.6% | 27.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.